reviewDrugsDec 8, 2014Closed access

Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

ASAndré Scheen

University of Liège

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

559
total citations
FWCI
27.92
Percentile
100%
References
158
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Empagliflozin
  • Dapagliflozin
  • Medicine
  • Canagliflozin
  • Renal glucose reabsorption
  • Metformin
  • Sitagliptin
  • Pharmacology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.